CompaniesNeurizon Therapeutics
Neurizon Therapeutics logo

Neurizon Therapeutics

active
Claremont, Australia
Founded 2000
Website
About

Cancer Therapeutics

Areas of Focus

Categories

Small Molecule PharmaceuticalAustralia
Team (13)
Dan O’Connell
Dan O’Connell
Neurizon Therapeutics
team_member
Dr Carol Worth
Dr Carol Worth
Neurizon Therapeutics
team_member
Dr Chris Freitag
Dr Chris Freitag
Neurizon Therapeutics
team_member
Dr Herbert Brinkman
Dr Herbert Brinkman
Neurizon Therapeutics
team_member
Dr Jeffrey M. Brown
Dr Jeffrey M. Brown
Neurizon Therapeutics
team_member
Dr Katie MacFarlane
Dr Katie MacFarlane
Neurizon Therapeutics
team_member
View all 13 team members →
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

24

By Phase

PHASE1: 2

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
Today
NCT04894240
NCT06177431
Hover over trial bars to see details

Recent Trials

NCT06177431Lead Sponsor
An Open Label Extension Study of Monepantel in Individuals With Motor Neurone Disease
PHASE1Completed
12 participants
Started: Feb 13, 2024 · Completed: May 30, 2025
NCT04894240Lead Sponsor
A Study of Monepantel in Individuals With Motor Neurone Disease
PHASE1Completed
12 participants
Started: Jun 28, 2022 · Completed: Nov 29, 2023
Locations (1)
Headquarters
Claremont, Australia
Map

Loading map...